The activation of FPR2 using selective agonists has been shown to induce therapeutic effects for several infectious- or inflammatory diseases such as polymicrobial sepsis, ulcerative colitis, and certain cancers17,21,22. Here, FPR2 is linked to ulcerative colitis.